Does OCRELIZUMAB Cause Initial insomnia? 119 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 119 reports of Initial insomnia have been filed in association with OCRELIZUMAB (OCREVUS). This represents 0.2% of all adverse event reports for OCRELIZUMAB.
119
Reports of Initial insomnia with OCRELIZUMAB
0.2%
of all OCRELIZUMAB reports
1
Deaths
61
Hospitalizations
How Dangerous Is Initial insomnia From OCRELIZUMAB?
Of the 119 reports, 1 (0.8%) resulted in death, 61 (51.3%) required hospitalization.
Is Initial insomnia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OCRELIZUMAB. However, 119 reports have been filed with the FAERS database.
What Other Side Effects Does OCRELIZUMAB Cause?
Covid-19 (11,454)
Fatigue (5,704)
Urinary tract infection (3,618)
Headache (3,036)
Multiple sclerosis (2,609)
Asthenia (2,509)
Nasopharyngitis (2,479)
Gait disturbance (2,384)
Pneumonia (2,333)
Pain (2,327)
What Other Drugs Cause Initial insomnia?
SODIUM OXYBATE (787)
DUPILUMAB (495)
CARBIDOPA\LEVODOPA (219)
TASIMELTEON (153)
QUETIAPINE (132)
LEVOTHYROXINE (102)
ADALIMUMAB (98)
DALFAMPRIDINE (98)
NIRAPARIB (96)
ZOLPIDEM (88)
Which OCRELIZUMAB Alternatives Have Lower Initial insomnia Risk?
OCRELIZUMAB vs OCRIPLASMIN
OCRELIZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OCRELIZUMAB vs OCTINOXATE\OCTOCRYLENE
OCRELIZUMAB vs OCTREOTIDE
OCRELIZUMAB vs OCTREOTIDE\OCTREOTIDE